E152 - Therapeutic Guidelines Diabetes
from Australian Prescriber Podcast
SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Australian Prescriber Podcast?
This episode is 16 minutes long.
When was this Australian Prescriber Podcast episode published?
This episode was published on December 4, 2023.
Can I download this Australian Prescriber Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.